Fmoc-OsuCAS# 82911-69-1 |
2D Structure
- PF-4708671
Catalog No.:BCC5031
CAS No.:1255517-76-0
- BIX 02565
Catalog No.:BCC4303
CAS No.:1311367-27-7
- BI-D1870
Catalog No.:BCC5030
CAS No.:501437-28-1
- CMK
Catalog No.:BCC1489
CAS No.:821794-90-5
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 82911-69-1 | SDF | Download SDF |
PubChem ID | 134122 | Appearance | Powder |
Formula | C19H15NO5 | M.Wt | 337.33 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in water or 1% acetic acid | ||
Chemical Name | (2,5-dioxopyrrolidin-1-yl) 9H-fluoren-9-ylmethyl carbonate | ||
SMILES | C1CC(=O)N(C1=O)OC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24 | ||
Standard InChIKey | WMSUFWLPZLCIHP-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C19H15NO5/c21-17-9-10-18(22)20(17)25-19(23)24-11-16-14-7-3-1-5-12(14)13-6-2-4-8-15(13)16/h1-8,16H,9-11H2 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Fmoc-Osu Dilution Calculator
Fmoc-Osu Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.9645 mL | 14.8223 mL | 29.6446 mL | 59.2891 mL | 74.1114 mL |
5 mM | 0.5929 mL | 2.9645 mL | 5.9289 mL | 11.8578 mL | 14.8223 mL |
10 mM | 0.2964 mL | 1.4822 mL | 2.9645 mL | 5.9289 mL | 7.4111 mL |
50 mM | 0.0593 mL | 0.2964 mL | 0.5929 mL | 1.1858 mL | 1.4822 mL |
100 mM | 0.0296 mL | 0.1482 mL | 0.2964 mL | 0.5929 mL | 0.7411 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Fmoc-Osu
- 3-Oxo-24,25,26,27-tetranortirucall-7-en-23,21-olide
Catalog No.:BCN1338
CAS No.:828935-47-3
- (R)-(+)-Etomoxir sodium salt
Catalog No.:BCC7946
CAS No.:828934-41-4
- 2,3-Dihydroisoginkgetin
Catalog No.:BCN4035
CAS No.:828923-27-9
- Cyclo(Tyr-Leu)
Catalog No.:BCN2432
CAS No.:82863-65-8
- Echinacoside
Catalog No.:BCN4953
CAS No.:82854-37-3
- Pingpeimine B
Catalog No.:BCN8408
CAS No.:82851-52-3
- Pingpeimine A
Catalog No.:BCN8407
CAS No.:82841-67-6
- Perindopril
Catalog No.:BCC4223
CAS No.:82834-16-0
- cGMP Dependent Kinase Inhibitor Peptide
Catalog No.:BCC8084
CAS No.:82801-73-8
- H-D-HoPhe-OH
Catalog No.:BCC3239
CAS No.:82795-51-5
- Nefazodone hydrochloride
Catalog No.:BCC7479
CAS No.:82752-99-6
- DCPIB
Catalog No.:BCC7105
CAS No.:82749-70-0
- 7,4'-Dihydroxy-8-methylflavan
Catalog No.:BCN6841
CAS No.:82925-55-1
- CI 898 trihydrochloride
Catalog No.:BCC7248
CAS No.:82952-64-5
- Nafamostat Mesylate(FUT-175)
Catalog No.:BCC1228
CAS No.:82956-11-4
- 11-O-Galloylbergenin
Catalog No.:BCN6637
CAS No.:82958-44-9
- 4-O-Galloylbergenin
Catalog No.:BCN6643
CAS No.:82958-45-0
- Tolrestat
Catalog No.:BCC4084
CAS No.:82964-04-3
- 4-Aminoantipyrine
Catalog No.:BCC8683
CAS No.:83-07-8
- Phenindione
Catalog No.:BCC4699
CAS No.:83-12-5
- 1-Indanone
Catalog No.:BCN2245
CAS No.:83-33-0
- Methylprednisolone
Catalog No.:BCC2256
CAS No.:83-43-2
- Deoxycholic acid
Catalog No.:BCN1288
CAS No.:83-44-3
- Beta-Sitosterol
Catalog No.:BCN1015
CAS No.:83-46-5
Formation of Fmoc-beta-alanine during Fmoc-protections with Fmoc-OSu.[Pubmed:18219706]
J Pept Sci. 2008 Jun;14(6):763-6.
During the Fmoc-protection of H-alpha-Me-Val-OH, an unknown side product was found and isolated. The characterization using various analytical methods led unambiguously to the result that Fmoc-beta-Ala-OH was formed during the reaction. The reagent Fmoc-Osu was proven to be the source of Fmoc-beta-Ala-OH, following a mechanism that involved many deprotonation and elimination steps and a Lossen-type rearrangement as key sequence. The impurity Fmoc-beta-Ala-OH was found in a variety of reactions in which Fmoc-Osu was applied, either in the reaction mixture or as a contamination of the crude product. Purification of the Fmoc-amino acid derivatives from this impurity incurred high costs and significant reductions in yield.